<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="10" family="Symbol" color="#ffffff"/>
	<fontspec id="font9" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font10" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font11" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="10" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="137" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Cell Communication and Signaling</i></text>
<text top="41" left="192" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2005, </text>
<text top="41" left="220" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="225" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:10</text>
<text top="41" left="383" width="171" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.biosignaling.com/content/3/1/10</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="85" segment_no="7" tag_type="text">Page 5 of 10</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="86" segment_no="8" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="29" segment_no="4" tag_type="text">cAMPS. Cell pretreatment in serum-free DMEM contain-</text>
<text top="545" left="55" width="109" height="9" font="font4" id="p1_t9" reading_order_no="30" segment_no="4" tag_type="text">ing 100 nM of H-89 or 10 </text>
<text top="543" left="164" width="6" height="13" font="font5" id="p1_t10" reading_order_no="31" segment_no="4" tag_type="text">µ</text>
<text top="545" left="170" width="126" height="9" font="font4" id="p1_t11" reading_order_no="32" segment_no="4" tag_type="text">M of Rp-cAMPS did not signif-</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="33" segment_no="4" tag_type="text">icantly alter levels of pERK after stimulation with</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="34" segment_no="4" tag_type="text">isoproterenol when compared to cells preincubated in the</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="35" segment_no="4" tag_type="text">absence of PKA inhibitors (Figure <a href="">5). Incr</a>eases in pERK</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="36" segment_no="4" tag_type="text">when compared to basal were still detected following H-</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="37" segment_no="4" tag_type="text">89 or Rp-cAMPS pretreatment with peak levels generated</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="38" segment_no="4" tag_type="text">at 5 min. Semi-quantitave analysis of the immunoblots</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="39" segment_no="4" tag_type="text">revealed a 1.9 ± 0.4 and 2.6 ± 0.7 fold increase in pERK</text>
<text top="639" left="55" width="122" height="9" font="font4" id="p1_t19" reading_order_no="40" segment_no="4" tag_type="text">levels over basal after H-89 (</text>
<text top="639" left="178" width="8" height="9" font="font6" id="p1_t20" reading_order_no="41" segment_no="4" tag_type="text"><i>n </i></text>
<text top="639" left="186" width="84" height="9" font="font4" id="p1_t21" reading_order_no="42" segment_no="4" tag_type="text">= 4) or Rp-cAMPS (</text>
<text top="639" left="270" width="8" height="9" font="font6" id="p1_t22" reading_order_no="43" segment_no="4" tag_type="text"><i>n </i></text>
<text top="639" left="278" width="18" height="9" font="font4" id="p1_t23" reading_order_no="44" segment_no="4" tag_type="text">= 3)</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="45" segment_no="4" tag_type="text">pretreatment, respectively, which are not significantly dif-</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="46" segment_no="4" tag_type="text">ferent than the fold increase for pERK observed without</text>
<text top="674" left="55" width="145" height="9" font="font4" id="p1_t26" reading_order_no="47" segment_no="4" tag_type="text">inhibitor pretreatment (2.6 ± 0.9; </text>
<text top="674" left="200" width="8" height="9" font="font6" id="p1_t27" reading_order_no="48" segment_no="4" tag_type="text"><i>n </i></text>
<text top="674" left="208" width="88" height="9" font="font4" id="p1_t28" reading_order_no="49" segment_no="4" tag_type="text">= 4). Results of these</text>
<text top="686" left="55" width="138" height="9" font="font4" id="p1_t29" reading_order_no="50" segment_no="4" tag_type="text">experiments demonstrate that </text>
<text top="684" left="193" width="5" height="13" font="font5" id="p1_t30" reading_order_no="51" segment_no="4" tag_type="text">β</text>
<text top="686" left="198" width="98" height="9" font="font4" id="p1_t31" reading_order_no="52" segment_no="4" tag_type="text">-AR stimulated MAPK</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="53" segment_no="4" tag_type="text">activation in UROtsa cells is not dependent upon genera-</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="54" segment_no="4" tag_type="text">tion of cAMP production and subsequent activation of</text>
<text top="721" left="55" width="20" height="9" font="font4" id="p1_t34" reading_order_no="55" segment_no="4" tag_type="text">PKA.</text>
<text top="533" left="313" width="237" height="9" font="font7" id="p1_t35" reading_order_no="56" segment_no="5" tag_type="title"><i><b>PKA-Independent Production of Inflammatory Mediators</b></i></text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="57" segment_no="6" tag_type="text">Although previous results revealed that MAPK activation</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="58" segment_no="6" tag_type="text">is not dependent upon PKA activation, we were interested</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="59" segment_no="6" tag_type="text">in whether or not production of inflammatory mediators</text>
<text top="580" left="313" width="55" height="9" font="font4" id="p1_t39" reading_order_no="60" segment_no="6" tag_type="text">initiated by </text>
<text top="578" left="368" width="5" height="13" font="font5" id="p1_t40" reading_order_no="61" segment_no="6" tag_type="text">β</text>
<text top="580" left="374" width="180" height="9" font="font4" id="p1_t41" reading_order_no="62" segment_no="6" tag_type="text">-AR activation also occurred under PKA-</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="63" segment_no="6" tag_type="text">independent mechanisms. Pretreatment of UROtsa cells</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="64" segment_no="6" tag_type="text">with selective concentrations of H-89 (100 nM) or Rp-</text>
<text top="615" left="313" width="49" height="9" font="font4" id="p1_t44" reading_order_no="65" segment_no="6" tag_type="text">cAMPS (10 </text>
<text top="613" left="362" width="6" height="13" font="font5" id="p1_t45" reading_order_no="66" segment_no="6" tag_type="text">µ</text>
<text top="615" left="368" width="186" height="9" font="font4" id="p1_t46" reading_order_no="67" segment_no="6" tag_type="text">M), again did not affect production of COX-</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="68" segment_no="6" tag_type="text">2 or iNOS 2 hrs after addition of isoproterenol, when</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="69" segment_no="6" tag_type="text">compared to cells pretreated in the absence of inhibitor</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="70" segment_no="6" tag_type="text"><a href="">(Figure 6)</a>. In these experiments, levels of COX-2 gener-</text>
<text top="662" left="313" width="33" height="9" font="font4" id="p1_t50" reading_order_no="71" segment_no="6" tag_type="text">ated by </text>
<text top="660" left="346" width="5" height="13" font="font5" id="p1_t51" reading_order_no="72" segment_no="6" tag_type="text">β</text>
<text top="662" left="351" width="166" height="9" font="font4" id="p1_t52" reading_order_no="73" segment_no="6" tag_type="text">-AR activation in the presence of H-89 (</text>
<text top="662" left="518" width="8" height="9" font="font6" id="p1_t53" reading_order_no="74" segment_no="6" tag_type="text"><i>n </i></text>
<text top="662" left="525" width="29" height="9" font="font4" id="p1_t54" reading_order_no="75" segment_no="6" tag_type="text">= 3) or</text>
<text top="674" left="313" width="51" height="9" font="font4" id="p1_t55" reading_order_no="76" segment_no="6" tag_type="text">Rp-cAMPS (</text>
<text top="674" left="364" width="8" height="9" font="font6" id="p1_t56" reading_order_no="77" segment_no="6" tag_type="text"><i>n </i></text>
<text top="674" left="372" width="182" height="9" font="font4" id="p1_t57" reading_order_no="78" segment_no="6" tag_type="text">= 3) were increased 3.0 ± 0.4 and 2.5 ± 0.7</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="79" segment_no="6" tag_type="text">fold over basal, respectively. This level of COX-2</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="80" segment_no="6" tag_type="text">expression in response to isoproterenol was not signifi-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="81" segment_no="6" tag_type="text">cantly different from cells pretreated in the absence of</text>
<text top="721" left="313" width="148" height="9" font="font4" id="p1_t61" reading_order_no="82" segment_no="6" tag_type="text">inhibitor (1.9 ± 0.5 fold over basal; </text>
<text top="721" left="461" width="8" height="9" font="font6" id="p1_t62" reading_order_no="83" segment_no="6" tag_type="text"><i>n </i></text>
<text top="721" left="469" width="85" height="9" font="font4" id="p1_t63" reading_order_no="84" segment_no="6" tag_type="text">= 5). Likewise, levels</text>
<text top="357" left="55" width="5" height="13" font="font8" id="p1_t64" reading_order_no="5" segment_no="2" tag_type="title">β</text>
<text top="359" left="60" width="357" height="9" font="font9" id="p1_t65" reading_order_no="7" segment_no="2" tag_type="title">-AR stimulation activates the MAPK pathway after treatment with selective PKA inhibitors</text>
<text top="359" left="55" width="37" height="9" font="font10" id="p1_t66" reading_order_no="6" segment_no="2" tag_type="title"><b>Figure 5</b></text>
<text top="367" left="55" width="5" height="13" font="font5" id="p1_t67" reading_order_no="8" segment_no="3" tag_type="text">β</text>
<text top="370" left="60" width="413" height="9" font="font10" id="p1_t68" reading_order_no="9" segment_no="3" tag_type="text"><b>-AR stimulation activates the MAPK pathway after treatment with selective PKA inhibitors</b></text>
<text top="370" left="473" width="81" height="9" font="font11" id="p1_t69" reading_order_no="10" segment_no="3" tag_type="text">. After a 30 min pre-</text>
<text top="381" left="55" width="208" height="9" font="font11" id="p1_t70" reading_order_no="11" segment_no="3" tag_type="text">incubation with 100 nM of the PKA inhibitors H-89 (</text>
<text top="381" left="263" width="28" height="9" font="font12" id="p1_t71" reading_order_no="12" segment_no="3" tag_type="text"><i>panel A</i></text>
<text top="381" left="291" width="30" height="9" font="font11" id="p1_t72" reading_order_no="13" segment_no="3" tag_type="text">) or 10 </text>
<text top="378" left="321" width="6" height="13" font="font5" id="p1_t73" reading_order_no="14" segment_no="3" tag_type="text">µ</text>
<text top="381" left="327" width="68" height="9" font="font11" id="p1_t74" reading_order_no="15" segment_no="3" tag_type="text">M of Rp-cAMPS (</text>
<text top="381" left="395" width="28" height="9" font="font12" id="p1_t75" reading_order_no="16" segment_no="3" tag_type="text"><i>panel B</i></text>
<text top="381" left="423" width="129" height="9" font="font11" id="p1_t76" reading_order_no="17" segment_no="3" tag_type="text">), UROtsa cells were stimulated </text>
<text top="391" left="55" width="499" height="9" font="font11" id="p1_t77" reading_order_no="18" segment_no="3" tag_type="text">with 100 nM isoproterenol for the indicated times and immunoblotted with anti-pERK or anti-ERK2. Peak levels of pERK were </text>
<text top="402" left="55" width="493" height="9" font="font11" id="p1_t78" reading_order_no="19" segment_no="3" tag_type="text">observed within 5 min after the addition of isoproterenol with no changes in the total cell lysate levels of ERK2. Semi-quanti-</text>
<text top="413" left="55" width="374" height="9" font="font11" id="p1_t79" reading_order_no="20" segment_no="3" tag_type="text">tave analysis of the immunoblots revealed a time-dependent increase in ERK phosphorylation (</text>
<text top="413" left="429" width="28" height="9" font="font12" id="p1_t80" reading_order_no="21" segment_no="3" tag_type="text"><i>panel C</i></text>
<text top="413" left="457" width="81" height="9" font="font11" id="p1_t81" reading_order_no="22" segment_no="3" tag_type="text">). Five minutes after </text>
<text top="424" left="55" width="499" height="9" font="font11" id="p1_t82" reading_order_no="23" segment_no="3" tag_type="text">treatment, isoproterenol significantly induced a 1.9 ± 0.4 and 2.6 ± 0.7 fold increase in pERK levels over basal after H-89 or Rp-</text>
<text top="434" left="55" width="498" height="9" font="font11" id="p1_t83" reading_order_no="24" segment_no="3" tag_type="text">cAMPS pretreatment, respectively. These peak values are not significantly different than the fold increase over basal for pERK </text>
<text top="445" left="55" width="499" height="9" font="font11" id="p1_t84" reading_order_no="25" segment_no="3" tag_type="text">measured in the absence of PKA inhibitor (2.6 ± 0.9). Values are presented as the mean ± S.E. and the autoradiographs are rep-</text>
<text top="456" left="55" width="111" height="9" font="font11" id="p1_t85" reading_order_no="26" segment_no="3" tag_type="text">resentative immunoblots of </text>
<text top="456" left="166" width="7" height="9" font="font12" id="p1_t86" reading_order_no="27" segment_no="3" tag_type="text"><i>n </i></text>
<text top="456" left="173" width="173" height="9" font="font11" id="p1_t87" reading_order_no="28" segment_no="3" tag_type="text">= 3–4 independent UROtsa cell treatments.</text>
</page>
</pdf2xml>
